Troxerutin powder injection

Abstract

The troxerutin powder for injection includes troxerutin 2-100 wt% and excipient 0-98 wt%, and the excipient is one of mannitol, lactose, glycine, sorbic alcohol, low molecular weight dextran, glucose, cane sugar and hydrolysate gel. It is bacteria-free powder or bacteria-free freeze dried produce. The present invention is used in treating ischemic cerebral vascular diseases, central retinitis, arteriosclerosis, thrombotic phlebitis, varicosity, etc. and has the advantages of stability, fast dissolution in water and high safety.

Description

(1) Technical field

[0001] The invention relates to the technical field of medicine, in particular to a troxerutin powder injection. (2) Background technology

[0002] Troxerutin can inhibit platelet aggregation and prevent thrombosis. At the same time, it can resist vascular damage caused by 5-hydroxytryptamine and bradykinin, increase capillary resistance, reduce capillary permeability, and prevent edema caused by increased vascular permeability. Clinically, it has achieved good curative effect in the treatment of ischemic cerebrovascular disease, central retinitis, arteriosclerosis, thrombophlebitis, varicose veins, occlusive syndrome, capillary hemorrhage and edema caused by increased vascular permeability At present, troxerutin injections are marketed as water injections and infusions. However, water injections and infusions bring inconvenience to storage and transportation, and troxerutin sodium chloride injection is listed in the "Chemical Drugs Local Standards Upgra...